The Cyclopropane Fatty Acid Synthase Mediates Antibiotic Resistance and Gastric Colonization of Helicobacter pylori
Author(s) -
Xueqing Jiang,
Yuanyuan Duan,
Boshen Zhou,
Qiaoqiao Guo,
Haihong Wang,
Xudong Hang,
Liping Zeng,
Jia Jia,
Hongkai Bi
Publication year - 2019
Publication title -
journal of bacteriology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.652
H-Index - 246
eISSN - 1067-8832
pISSN - 0021-9193
DOI - 10.1128/jb.00374-19
Subject(s) - biology , helicobacter pylori , antibiotics , druggability , microbiology and biotechnology , gastritis , drug resistance , immune system , antibiotic resistance , enzyme , colonization , immunology , biochemistry , genetics , gene
The increasing prevalence of multidrug-resistantHelicobacter pylori strains has created an urgent need for alternative therapeutic regimens that complement the current antibiotic treatment strategies forH. pylori eradication; however, this is greatly hampered due to a lack of “druggable” targets. Although the CFAs are present inH. pylori cytoplasmic membranes at high levels, their physiological role has not been established. In this report, deletion of the CFA synthase CfaS was shown to attenuate acid and drug resistance, immune escape, and gastric colonization ofH. pylori . These findings were validated by inhibition of the CfaS activity with the tool compound dioctylamine. These studies identify this enzyme as an attractive target for further drug discovery efforts againstH. pylori .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom